Research uncovers possible monoclonal antibody treatment for Lassa fever
New research potentially points to an effective treatment for Lassa fever, a dangerous, often fatal disease common to much of West Africa but considered a major threat to global health.
Registered users, subscribers or members - SIGN IN
To continue reading this article
Subscribe
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.
Register
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
Membership
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
